November 20, 2004
Tarceva Approved for Lung Cancer, Cancer Cases in Sweden from Chernobyl
"The United States Food and Drug Administration (FDA) has recently approved the oral agent Tarceva® (erlotinib) for the treatment of advanced non-small cell lung cancer in patients who have received at least one prior therapeutic regimen."
"More than 800 people in northern Sweden may have cancer as a result of the fallout that spewed over the region after the Chernobyl nuclear accident in 1986."
